Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schuster

Showing results (471-480 of 630) with videos related to

Pageof 63
Sort By:
International Journal of Particle Therapy|March 11, 2026
Long Term Results of Proton Therapy in Adult Infradiaphragmatic LymphomaCecilia Jiang, Travis Hoover, Jonathan Baron, et al.
Journal of Biomedical Optics|December 18, 2013
Infrared skin damage thresholds from 1319-nm continuous-wave laser exposuresJeffrey W Oliver, Rebecca Vincelette, Gary D Noojin, et al.
Blood|September 6, 2018
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphomaJia Ruan, Peter Martin, Paul Christos, et al.
Heliyon|May 28, 2024
Vaginal microbiota and spontaneous preterm birth in pregnant women at high risk of recurrenceHeleen J Schuster, Anouk M Bos, Lisa Himschoot, et al.
Cancer Biology & Therapy|August 5, 2009
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignanciesAnthony Mato, Barry D Fuchs, Daniel F Heitjan, et al.
American Journal of Hematology|December 6, 2019
Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphomaLei Qian, Craig Soderquist, April Schrank-Hacker, et al.
Frontiers in Oncology|July 24, 2019
Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma CellsQian Zhang, Hong Y Wang, Xiaobin Liu, et al.
JCI Insight|February 8, 2019
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypesEllis Y Kim, David Y Barefield, Andy H Vo, et al.
Advances in Experimental Medicine and Biology|March 30, 2011
NMR metabolic and physiological markers of therapeutic responseSeung-Cheol Lee, Harish Poptani, E James Delikatny, et al.
Blood Advances|January 18, 2019
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapyDaniel J Landsburg, Mitchell E Hughes, Alexa Koike, et al.
Pageof 63

Showing results (471-480 of 630) with videos related to

Sort By:
Pageof 63
International Journal of Particle Therapy|March 11, 2026
Long Term Results of Proton Therapy in Adult Infradiaphragmatic LymphomaCecilia Jiang, Travis Hoover, Jonathan Baron, et al.
Journal of Biomedical Optics|December 18, 2013
Infrared skin damage thresholds from 1319-nm continuous-wave laser exposuresJeffrey W Oliver, Rebecca Vincelette, Gary D Noojin, et al.
Blood|September 6, 2018
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphomaJia Ruan, Peter Martin, Paul Christos, et al.
Heliyon|May 28, 2024
Vaginal microbiota and spontaneous preterm birth in pregnant women at high risk of recurrenceHeleen J Schuster, Anouk M Bos, Lisa Himschoot, et al.
Cancer Biology & Therapy|August 5, 2009
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignanciesAnthony Mato, Barry D Fuchs, Daniel F Heitjan, et al.
American Journal of Hematology|December 6, 2019
Deletion 20q12 is associated with histological transformation of nodal marginal zone lymphoma to diffuse large B-cell lymphomaLei Qian, Craig Soderquist, April Schrank-Hacker, et al.
Frontiers in Oncology|July 24, 2019
Dynamic Changes in Gene Mutational Landscape With Preservation of Core Mutations in Mantle Cell Lymphoma CellsQian Zhang, Hong Y Wang, Xiaobin Liu, et al.
JCI Insight|February 8, 2019
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypesEllis Y Kim, David Y Barefield, Andy H Vo, et al.
Advances in Experimental Medicine and Biology|March 30, 2011
NMR metabolic and physiological markers of therapeutic responseSeung-Cheol Lee, Harish Poptani, E James Delikatny, et al.
Blood Advances|January 18, 2019
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapyDaniel J Landsburg, Mitchell E Hughes, Alexa Koike, et al.
Pageof 63